Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Abstract Text:

Arthur L Burnett,

The contemporary use of anatomic nerve-sparing radical prostatectomy, which entails preserving the autonomic nerve supply to the penis required for penile erection, has led to improved erectile function outcomes compared with what has been seen historically. However, delay of postoperative recovery of erection for as long as 2 years is common, such that dysfunctional erection status lingers as a major postoperative problem. Several possible strategies to improve overall recovery rates and to hasten postoperative recovery of erectile function are currently being advanced. These include pharmacologic rehabilitation therapy and neuromodulatory therapy. Rigorous basic scientific investigation and clinical assessment of these new strategic approaches are critically important to establish their actual therapeutic benefits.

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Publishing Authors By Initials

AL Burnett,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Reviews in urology

VOLUME: 8

Page Numbers: 47-53

Journal Abbreviation:

ISSN: 1523-6161

DAY: 5

MONTH: 10

YEAR: 2006

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100889067

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Rev Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy Related Publications

• A method for isolating living polymorphonuclear leukocytes from peripheral blood.
• An early regime for severe finger injuries.
• Anomalous channel between aorta and right ventricle; report of a case.
• Association between maternal exposure to ambient air pollutants during pregnancy and fetal growth restriction.
• BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.
• Cystic emphysema of the lungs.
• Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
• Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.
• Does androgen suppression plus radiation therapy lead to changes in penile length in prostate cancer patients?
• Effectiveness of repellents applied to clothing for protection against salt-marsh mosquitoes.
• Erectile function outcomes in the current era of anatomic nerve-sparing radical prostatectomy.
• Erythropoietin receptor expression in the human urogenital tract: immunolocalization in the prostate, neurovascular bundle and penis.
• Ethical considerations in the use of DNA for the diagnosis of diseases.
• FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms.
• Large-scale purification and crystallization of adenovirus hexon.
• MRC trials in acute myeloblastic luekemia: Where have we got to?
• Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU.
• Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health.
• NADPH oxidase: recent evidence for its role in erectile dysfunction.
• Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular disease.
• Periodically poled BaMgF(4) for ultraviolet frequency generation.
• Refractivity of nitrogen gas in the vacuum ultraviolet.
• Review of meningioma histopathology.
• Rights and the reality of healthcare charging in the United Kingdom.
• Roaches; how to identify and principles of control.
• Sapropterin dihydrochloride (Kuvan/phenoptin), an orally active synthetic form of BH4 for the treatment of phenylketonuria.
• The perforated appendix.
• Unusual strangulated hernias in infants.
• Validation and feasibility of intraoperative three-dimensional transesophageal echocardiographic cardiac output.
• Vulnerable elders: when it is no longer safe to live alone.